Location: Home
  • search
  • go
  • Relate News
  • 3/31/2026Huahui Launches World's First Approved Hepatitis D Antibody Drug in Ch...
  • 3/31/2026NMPA Moves to Strengthen China's Conditional Drug Approval Framework
  • 3/31/2026NHSA Deepens Dialogue With MNC Pharma on Innovation Drug Value and Rea...
  • 3/31/2026IMPACT Therapeutics Renews Hong Kong IPO Push With Updated Filing
  • 3/30/2026GSK's Exdensur Wins China Approval for Severe Eosinophilic Asthma
  • 3/30/2026AZ/Amgen's Tezspire Wins China Approval for Asthma and CRSwNP
  • 3/30/2026Almirall Partners Shanghai Huaota in $340 Million Dermatology Antibody...
  • 3/30/2026China Approves Claruvis's Retoxin, Marking New Milestone in Recombinan...
  • 3/30/2026BioRay and UCB Win Dual China Dermatology Approvals for Bimzelx
  • 3/30/2026Enhertu Wins First Global Approval in Neoadjuvant HER2-Positive Early ...
  • 3/27/2026China Pharma Market Set for Structural Shift as Innovation and Cost Pr...
  • 3/27/2026GSK Partners Shanghai Pharma to Reintroduce Hepatitis B Vaccine in Chi...
  • 3/27/2026SK Biopharma Launches Epilepsy Drug Cenobamate in China
  • 3/27/2026Recent Executive Moves
  • 3/25/2026Hope Medicine Advances HMI-115 Into Phase III for Endometriosis
  • 3/25/2026Innovent Reports Positive Phase 3 STAR Results for IBI302 in nAMD
  • 3/25/2026Gilead Nears $2B Ouro Deal Anchored by China-Origin BCMA/CD3 Asset
  • 3/25/2026BrightGene Reports Positive Phase 1 Data for Oral GLP-1/GIP Weight-Los...
  • 3/25/2026China Suspends Imports of Select Indian APIs Over GMP Violations
  • 3/25/2026Innovent Eyes China Approval as IBI302 Matches Eylea in Phase 3 nAMD S...
  • 3/25/2026IQVIA Report Highlights Rising Use and Intensifying Competition in Chi...
  • 3/24/2026Global Pharma Ramps Up China Investment as 15th Five-Year Plan Priorit...
  • 3/24/2026Novartis Commits $480M to Expand China Footprint
  • 3/24/2026WuXi AppTec Leans Further on US Market as Other Revenues Weaken
  • 3/24/2026RemeGen's Disitamab Vedotin Approved in China for HER2-Low Breast Canc...
  • 3/24/2026Chinese Commerce Minister Meets PhRMA, MNC Executives to Discuss Indus...
  • 3/23/2026HUTCHMED Advances HMPL-760 Into Phase III Trial for DLBCL in China
  • 3/23/2026SkyeMedicine Raises ¥100M+ Seed to Advance Multi-Target CAR-T Pipelin...
  • 3/23/2026MediLink Thera Reports Phase II Activity for YL202/BNT326 in NSCLC
  • 3/23/2026Mabgalaxy Raises Near CNY 100M Angel Round to Advance AI-Driven Antibo...
  • Page:2/384 Total number of articles:11506: [First][<<] [1] [2] [3] [4] [5] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group